I-Mab Biopharma and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Study of TJ202/MOR202 in Multiple Myeloma Apr 29, 2019 Life Science
Luye Pays $5 Million Upfront for China Rights to PharmaMar’s SCLC Treatment Apr 29, 2019 Life Science
Everest Pays $65 Million Upfront in $835 Million Agreement for Greater China Rights to Immunomedics ADC Apr 29, 2019 Life Science
QTC Care Closes 7 million USD Series-A Financing – Focusing on Introducing Global Top Medical Resources to China and Advancing Health Management Platforms Apr 26, 2019 Life Science
Crescita Therapeutics Signs Pliaglis Out-Licensing Agreement with Cantabria Labs for $2.5M Upfront After Reacquiring Rest-of-World Rights Apr 25, 2019 Life Science
Eddingpharma to Pay $375 Million for Two Lilly Antibiotics and a Suzhou Factory Apr 23, 2019 Life Science
Rapid Medical Raises $20 Million in New Funding to Support Clinical and Commercialization of First-in-class Stroke Treatment Products Apr 22, 2019 Life Science
